Attenuated Glutamine Synthetase Selection Marker

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The current methods for generating stable cell lines for biologic production are labor-intensive and time-consuming, requiring the isolation of hundreds of single clones and assessment of stability over at least 60 generations using the glutamine synthetase (GS) selection system.

Innovation Solution

Development of an expression vector containing a polynucleotide encoding a glutamine synthetase with reduced activity, allowing for the selection of cells with higher copy numbers of the expression cassette and eliminating the need for GS inhibitors like methionine sulphoximine (MSX).

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If wild type glutamine synthetase is used as selection marker with GS inhibitor, then selection stringency is improved, but the process requires isolation of hundreds of clones and stability assessment over 60 generations which is labor-intensive and time-consuming

Engineering Contradiction:
Improveselection stringencyVSAvoidtime for stable cell line generation
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent applies parameter changes by modifying the glutamine synthetase enzyme's catalytic activity through site-directed mutagenesis. Specific amino acid residues in the active site (such as Ser257, Ser260, Ser263, or Ser344) are mutated to reduce enzymatic activity while preserving substrate binding. This creates an attenuated GS marker that provides sufficient selection pressure without requiring extensive clone screening and stability assessment, thereby reducing the time and labor required for stable cell line generation while maintaining reliable selection stringency.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If GS inhibitor is added to amplify copy number, then selection effectiveness is improved, but the process becomes more complex and requires additional reagents

Engineering Contradiction:
Improveselection effectivenessVSAvoidselection system complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent extracts and removes the requirement for external GS inhibitors from the selection system. By incorporating mutations directly into the glutamine synthetase gene that reduce its catalytic activity, the selection pressure is generated endogenously by the attenuated enzyme itself. This eliminates the need for additional inhibitor reagents, simplifies the selection protocol, and reduces system complexity while maintaining effective selection for high-copy number integrants.

Inventive Principle:
Principle #2Taking out (Extraction)

3Measurement precision

If hundreds of single clones are isolated for screening, then high producer identification is improved, but labor intensity and time consumption increase significantly

Engineering Contradiction:
Improveproductivity assessment accuracyVSAvoidcell line generation efficiency
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The patent applies parameter changes to the selection marker's enzymatic activity to create a more efficient screening system. The attenuated GS marker (with reduced catalytic activity due to mutations in residues like Ser257, Ser260, Ser263, or Ser344) provides stronger selection pressure that enriches for high-copy number integrants directly in the pooled population. This allows accurate identification of high producers without isolating and screening hundreds of individual clones, thereby maintaining productivity assessment accuracy while dramatically improving cell line generation efficiency.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enhances the efficiency of identifying high-producing cell lines by increasing the stringency of selection and improving stability, while reducing the time and effort required in generating stable cell lines.

Implementation Method 1

a polynucleotide encoding a glutamine synthetase with reduced activity compared to a wild type glutamine synthetase

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Data Source

PatentUS20250136966A1Attenuated glutamine synthetase as a selection marker
Publication Date: 2025.05.01 AGENCY FOR SCI TECH & RES
  • US20250136966A1 patent drawing
  • US20250136966A1 patent drawing
  • US20250136966A1 patent drawing

AI summary

Disclosed is an expression vector comprising a polynucleotide encoding for a glutamine synthetase with reduced activity compared to a wild type glutamine synthetase. Also disclosed are host cells, methods for preparing stable cell line, methods of producing polypeptide of interest, and kits thereof.